Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.7%

5 terminated out of 65 trials

Success Rate

87.8%

+1.3% vs benchmark

Late-Stage Pipeline

31%

20 trials in Phase 3/4

Results Transparency

17%

6 of 36 completed with results

Key Signals

6 with results88% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (19)
P 1 (4)
P 2 (3)
P 3 (10)
P 4 (10)

Trial Status

Completed36
Unknown16
Terminated5
Recruiting3
Withdrawn3
Suspended1

Trial Success Rate

87.8%

Benchmark: 86.5%

Based on 36 completed trials

Clinical Trials (65)

Showing 20 of 20 trials
NCT07474649Phase 3Not Yet RecruitingPrimary

A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

NCT05708547CompletedPrimary

Role of Mitophagy in Myeloid Cells During Coronary Atherosclerosis.

NCT06831409Recruiting

Using CTA Measures to Define Cardiac Risk In NFL Alumni

NCT03504956Not ApplicableRecruitingPrimary

Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

NCT05660798Not ApplicableRecruiting

Effects of Switching From Cigarettes to Tobacco Heating System on Coronary Atherosclerosis Progression

NCT01030328Phase 3WithdrawnPrimary

AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis

NCT02316782CompletedPrimary

Bifurcation Lesion Analysis and STenting / BLAST

NCT02265146WithdrawnPrimary

ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy Study

NCT02440646TerminatedPrimary

Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging

NCT03087175Not ApplicableCompleted

MGuard Stent and Microcirculation

NCT02208765Not ApplicableUnknown

Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity

NCT05105750Phase 4UnknownPrimary

A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis

NCT00294567Phase 4Completed

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

NCT04559191Phase 4UnknownPrimary

Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring

NCT02151812Not ApplicableCompleted

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)

NCT01254552Phase 4Completed

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

NCT01581632Phase 1CompletedPrimary

Assessment of Coronary Plaque Composition

NCT02000661Phase 4Terminated

Routine Versus Selective Use of FFR to Guide PCI

NCT00811772Not ApplicableCompletedPrimary

Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis

NCT02926807Completed

Trial on Vascular Inflammation in Atopic Dermatitis

Scroll to load more

Research Network

Activity Timeline